flow study semaglutide FLOW- the Visual Abstract — NephJC Effects of semaglutide with and

Caution should be taken with a history of pancreatitis, active gallbladder disease, severe depression, or kidney failure

So while there is a long road ahead with plenty of potential land mines along the way, this health researcher is cautiously optimistic about the promise of these new tools to help our metabolic and cardiovascular health

While her diabetes management has improved, the risk of recurrent bowel obstruction remains a concern, especially given her history of prior obstruction

Conclusion GLP-1 therapy represents a significant advancement in weight management, offering both metabolic and appetite-regulating benefits

GLP-1 medications can make it challenging to consume adequate protein through whole foods alone, particularly when appetite is suppressed or gastrointestinal side effects such as nausea occur

GLP-1 receptor agonists like semaglutide have transformed weight loss outcomes for millions of patients, with clinical trials showing average weight reductions of 1522% of baseline body weight